Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

This study is currently recruiting participants.

Verified by Instituto Valenciano de Infertilidad, Spain, March 2007

Sponsored by:	Instituto Valenciano de Infertilidad, Spain
Information provided by:	Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier:	NCT00447850

Purpose

Previous studies have suggested that premature luteinization (PL)during controlled ovarian stimulation (COS) decreases the implantation rate due to a negative effect on the endometrium receptivity. This study aims to describe the impact on endometrial gene expression of PL in GnRH antagonist and GnRH agonist cycles.

Condition	Intervention
Premature Luteinization	Procedure: endometrial biopsy

U.S. FDA Resources

Study Type:	Interventional
Official Title:	Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

Further study details as provided by Instituto Valenciano de Infertilidad, Spain:

Study Start Date:

April 2007

Eligibility

Ages Eligible for Study:	18 Years to 35 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Oocyte donors
Age between 18-35 years old
BMI 18-29
NORMOGONADOTROPHICS
PROGESTERONE ≥ 1.2 ng/ml on hCG day

Exclusion Criteria:

PolyCystic Ovarian Syndrome (PCOS)
Endometriosis

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00447850

Locations

Spain
Ivi Valencia	Recruiting
VALENCIA, Spain, 46015
Contact: ELENA LABARTA, MD (34) 96 3050900 elabarta@ivi.es
Principal Investigator: Dra. Elena Labarta, MD

Sponsors and Collaborators

Instituto Valenciano de Infertilidad, Spain

Investigators

Principal Investigator:

Elena Labarta, MD

Instituto Valenciano de la Infertilidad

More Information

Responsible Party:	Instituto Valenciano de Infertilidad ( Dr. Elena Labarta )
Study ID Numbers:	VLC-EL-1006- 307-2
Study First Received:	March 13, 2007
Last Updated:	June 30, 2008
ClinicalTrials.gov Identifier:	NCT00447850
Health Authority:	Spain: Comité Ético de Investigación Clínica

ClinicalTrials.gov processed this record on January 16, 2009